Home / Recalls / Meitheal Pharmaceuticals Inc / D-0801-2021

D-0801-2021 Class III Terminated

Recalled by Meitheal Pharmaceuticals Inc — Chicago, IL

Recall Details

Product Type: Drugs
Report Date: September 22, 2021
Initiation Date: September 3, 2021
Termination Date: May 12, 2024
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 1,160 ten-pack cartons

Product Description

Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution Pattern

Nationwide within the USA and India

Code Information

Lot #: G0010120, Exp. Date December 2021; G0080520, Exp. Date April 2022; G0090221, G0100221, Exp. Date January 2023